产品编号 :
Cas No. :
| 包装规格 | 纯度 | 目录价 | 会员专享价 | 库存 | 数量 |
|---|---|---|---|---|---|
| 5mg | 95% | 询价 | |||
| 10mg | 95% | 询价 | |||
| 25mg | 95% | 询价 | |||
| 50mg | 95% | 询价 | |||
| 100mg | 95% | 询价 |
| 包装规格 | 纯度 | 目录价 | 会员专享价 | 库存 | 数量 |
|---|---|---|---|---|---|
| 5mg | 95% | 询价 | |||
| 10mg | 95% | 询价 | |||
| 25mg | 95% | 询价 | |||
| 50mg | 95% | 询价 | |||
| 100mg | 95% | 询价 |
CAS No. |
641571-15-5 |
|---|---|
中文名称 |
4-甲基-N-(3-(5-甲基-1H-咪唑-1-基)-5-(三氟甲基)苯基)-3-((4-(吡啶-3-基)嘧啶-2-基)氨基)苯甲酰胺 |
英文名称 |
4-Methyl-N-(3-(5-methyl-1H-imidazol-1-yl)-5-(trifluoromethyl)phenyl)-3-((4-(pyridin-3-yl)pyrimidin-2-yl)amino)benzamide |
别名 |
4-Methyl-N-(3-(5-Methyl-1H-iMidazol-1-yl)-5-(trifluoroMethyl)phenyl)-3-((4-(pyridin-3-yl)pyriMidin-2-yl)aMino)benzaMide;Nilotinib Regio Isomer;Nilotinib Impurity 13 (Nilotinib EP Impurity H);NilotinibImpurity H;Nilotinib Impurity 9 (Nilotinib EP Impurity H);Nilotinib Impurity04 |
标准英文名 |
4-methyl-N-(3-(5-methyl-1H-imidazol-1-yl)-5-(trifluoromethyl)phenyl)-3-((4-(pyridin-3-yl)pyrimidin-2-yl)amino)benzamide |
分子式 |
C28H22F3N7O |
分子量 |
529.53 |
精确分子量 |
529.18 |
SMILES |
O=C(NC1=CC(C(F)(F)F)=CC(N2C(C)=CN=C2)=C1)C3=CC=C(C)C(NC4=NC=CC(C5=CC=CN=C5)=N4)=C3 |
标准SMILES |
CC1=CC=C(C=C1NC1N=C(C=CN=1)C1C=NC=CC=1)C(=O)NC1C=C(C=C(C=1)C(F)(F)F)N1C=NC=C1C |
性状 |
Powder or crystals |
用途 |
For laboratory research purposes. Not for drug or household use. |
信号词 |
Danger |
InChIKey |
LVVDYLLEWIHKDY-UHFFFAOYSA-N |
危险类别(旧) |
H303,H372,H413 |
存储要求 |
Keep in dark place,Inert atmosphere,2-8°C,Keep container tightly closed in a dry and well-ventilated area. Containers which are opened must be carefully resealed and kept upright to prevent leakage. |
危险品分类 |
Acute toxicity, oral (Category 5),Specific target organ toxicity, repeated exposure (Category 1),Hazardous to the aquatic environment, long-term hazard (Category 4) |
|---|---|
化学稳定性 |
Stable under recommended storage conditions. |
符号 |
|
|
|
评论 |
|---|